San Diego biotech news: Eli Lilly inks deal that could lead to $1B ...

Jul 9, 2024 · San Diego's Radionetics inked deal with Eli Lilly to advance its oncology pipeline ... San Diego biotech news: Eli Lilly inks deal that could lead to $1B acquisition of this local …

CouponFollow Extension

$1
OFF

San Diego Biotech News: Eli Lilly Inks Deal That Could Lead To $1B ...

4 weeks from now

Jul 9, 2024 · San Diego's Radionetics inked deal with Eli Lilly to advance its oncology pipeline ... San Diego biotech news: Eli Lilly inks deal that could lead to $1B acquisition of this local …

sandiegouniontribune.com

$1
OFF

Eli Lilly Inks Another Radiopharma Deal, Gaining Option To Buy Startup

4 weeks from now

Jul 1, 2024 · Eli Lilly is expanding further into radiopharmaceuticals, inking a deal with Radionetics Oncology that gives it an option to later acquire the San Diego biotechnology company for $1 …

biopharmadive.com

$2
OFF

Biotech – San Diego Union-Tribune

4 weeks from now

Oct 30, 2024 · San Diego’s Halozyme withdraws $2.1B Evotec bid, just one week after making offer ... San Diego biotech news: Eli Lilly inks deal that could lead to $1B acquisition of this …

sandiegouniontribune.com

$1
OFF

San Diego Biotech News: Eli Lilly Inks Deal That Could Lead To $1B ...

4 weeks from now

Jul 8, 2024 · Radionetics, a San Diego company working on a novel cancer treatment, just signed a big partnership with pharmaceutical giant Eli Lilly and Company. A key part of this strategic …

allsides.com

$1
OFF

Lilly Inks Potential $1.1B Radiopharma Deal With Aktis Oncology

4 weeks from now

May 21, 2024 · Lilly is also making an undisclosed equity investment in Aktis. The deal builds on previous investments in radiopharma. Lilly dropped $1.4 billion to acquire Point Biopharma in …

biospace.com

$1
OFF

Lilly Lays Down $1B To Be ‘first In Biology’ With Obesity Gene ...

4 weeks from now

Sep 9, 2024 · Last week, Lilly struck a deal with Haya Therapeutics, a Switzerland and San Diego-based biotech in the early phases of lncRNA development targeting chronic diseases. …

pharmavoice.com

$1
OFF

Lilly To Build New Pearly Gate(way) In Sunny San Diego - Fierce …

4 weeks from now

Nov 28, 2023 · The San Francisco outpost, which is spread across two locations, houses a total of 15 companies that have raised a combined total of $1 billion while working out of the labs …

fiercebiotech.com

FAQs about San Diego biotech news: Eli Lilly inks deal that could lead to $1B ... Coupon?

Will Eli Lilly buy radionetics oncology?

Scott Olson via Getty Images Eli Lilly is expanding further into radiopharmaceuticals, inking a deal with Radionetics Oncology that gives it an option to later acquire the San Diego biotechnology company for $1 billion. Lilly will pay Radionetics $140 million upfront for the option rights under the deal, which the companies announced Monday. ...

Does Eli Lilly have a biotech hub in San Diego?

By the way, in true SD fashion, this news is kind of a big deal: Lilly only has three other Gateway Labs in the US — two that opened in San Francisco in 2019 and 2022, and another in development for Boston in 2024. As a biotech hub, San Diego is about to get a big boost in 2024 by way of a new accelerator lab via Eli Lilly and Company. ...

How much will Lilly pay radionetics?

Lilly will pay Radionetics $140 million upfront for the option rights under the deal, which the companies announced Monday. Radionetics will continue to build its radiopharmaceutical drug pipeline through an “exercise period,” after which Lilly can choose whether to acquire the company. ...

Does Lilly have a biotech build-out?

The surge in investment has helped to drive a biotech build-out in capacity. Lilly has already been active in the field this year, paying startup Aktis Oncology $60 million in May for rights to develop treatments discovered by the company against targets selected by Lilly. ...

Will Lilly buy radionetics?

Radionetics will continue to build its radiopharmaceutical drug pipeline through an “exercise period,” after which Lilly can choose whether to acquire the company. Radionetics is developing small molecule radiopharmaceuticals that can target G protein-coupled receptors, a ubiquitous family of proteins that present many attractive disease targets. ...

Why did Lilly partner with aktis oncology in 2024?

In May 2024, Lilly partnered with Aktis Oncology for $60 million upfront and the promise of $1.1 billion in royalties. The deal gave Lilly worldwide rights to develop certain radiopharma therapies and diagnostics discovered by Aktis based on specific targets. ...